CVS Health Corp (CVS)

CVS (NYSE:Health Services) EQUITY
$104.92
pos +0.11
+0.10%
Today's Range: 104.73 - 105.70 | CVS Avg Daily Volume: 4,409,700
Last Update: 06/30/15 - 3:44 PM EDT
Volume: 2,811,217
YTD Performance: 8.83%
Open: $105.37
Previous Close: $104.81
52 Week Range: $74.69 - $106.88
Oustanding Shares: 1,128,330,774
Market Cap: 119,422,529,120
6-Month Chart
TheStreet Ratings Grade for CVS
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 14 12 13 13
Moderate Buy 3 3 3 3
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.25 1.28 1.26 1.26
Latest Dividend: 0.35
Latest Dividend Yield: 1.32%
Dividend Ex-Date: 04/22/15
Price Earnings Ratio: 25.94
Price Earnings Comparisons:
CVS Sector Avg. S&P 500
25.94 25.90 26.65
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
2.25% 38.42% 124.29%
GROWTH 12 Mo 3 Yr CAGR
Revenue 9.90 0.30 0.09
Net Income 1.10 0.33 0.10
EPS 5.90 0.54 0.15
Earnings for CVS:
EBITDA 10.73B
Revenue 139.37B
Average Earnings Estimates
Qtr (06/15) Qtr (09/15) FY (12/15) FY (12/16)
Average Estimate $1.20 $1.37 $5.16 $5.91
Number of Analysts 22 22 24 25
High Estimate $1.22 $1.44 $5.25 $6.19
Low Estimate $1.18 $1.31 $5.09 $5.60
Prior Year $1.13 $1.15 $4.22 $5.16
Growth Rate (Year over Year) 5.95% 19.01% 22.38% 14.52%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands

updateJefferies Consumer Conf.

Jun 23, 2015 | 6:52 AM EDT

Jefferies Consumer Conference (Day 1 of 2) - 06/23/15 - 06/24/15 Nantucket, MA

bullishCVS Health rated new Outperform at Oppenheimer

Jun 18, 2015 | 7:26 AM EDT

CVS was initiated with an Outperform rating, Oppenheimer said. $119 price target. Focus on health can drive growth. 

By

David Katz

 | Jun 16, 2015 | 2:00 PM EDT

It is a win-win for the companies and stocks.

By

Christopher Versace

 | Jun 16, 2015 | 12:00 PM EDT

Margins continue to be hurt by incentives and concessions.

By

Brian Sozzi

 | Jun 16, 2015 | 11:00 AM EDT

Both chains' new CEOs are shaking things up, but TGT is winning.

By

Jim Cramer

 | Jun 15, 2015 | 3:17 PM EDT

Take advantage of irrational collateral damage to stocks.

By

Jack Mohr

 | Jun 15, 2015 | 12:00 PM EDT

We applaud the deal with CVS Health, which allows Target to focus on its more profitable categories.

By

Sebastian Silva

 | Jun 14, 2015 | 8:20 PM EDT

But investors are likely to be wary ahead of the Fed meeting.

By

David Katz

 | May 29, 2015 | 8:30 AM EDT

Will it get involved in health care sector's deal mania?

By

Jim Cramer

 | May 21, 2015 | 6:49 PM EDT

Deals coming fast and furious in the best group in town.

Is it just me or has there been a distinct lack of negative pre-earnings announcements thu...
With one of the biggest moves ever in ONE DAY yesterday (top 10 all time), the market is s...

Risky CMBS tranches price at widest levels since 2013.

Sure the bulls are more fearful, if only for one reason. After a 6-plus year bull market, ...

REAL MONEY PRO'S BEST IDEAS

News Breaks

Powered by

Columnist Tweets

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.